2023-01-09 - Cancer Synoptic Reporting Project Group Meeting

2023-01-09 - Cancer Synoptic Reporting Project Group Meeting

Cancer Synoptic Reporting Project Group

9-January-2023 at 15:30 - 16:30 UTC

Attendees 

Scott Campbell Jieun Hwang  dubois  Laszlo Igali (Unlicensed) Jim Case  @brianrous Nicola Ingram @rosssimpson Thomas Ruediger (Unlicensed) @kerenhulkower  Suzanne Santamaria @ericdaley Keng-Ling Wallin (Unlicensed) Elaine Wooler Ekaterina Bazyleva (Unlicensed) 

 

Discussion items

Item

Description

Owner

Notes

Action

Item

Description

Owner

Notes

Action

1

Record meeting

Scott Campbell 

 

 

 Cannot do!  Not a host Done!!

2

Closing gaps in content - dysplasia and neoplasia at margins

Scott Campbell 

  1. Need references

  2. Questions:

    1. When is a #plasia generalized vs. localized (i.e., by organ)

 

 

  1. Definitions of high-grade/low-grade glandular dysplasia

  2. Definitions of high-grade/low-grade glandular intraepithelial neoplasia

  3. Definitions of high-grade/low-grade squamous intraepithelial neoplasia

  4. Sample of observable entity concepts created

Observable entity concepts are fine.  Jim Case asked for documentation on the *plasias and High-/Low- grading definitions as supporting documentation for ongoing use

Scott Campbell will draft a "blurb" and pathologists on the call will provide appropriate citations.

 

1/9/2023 - HG dysplasia vs. CIS.

Discussed the use of HG dysplasia, carcinoma in situ (CIS), and the and/or version.  This needs to be reviewed as the and/or for lymphovascular invasion body structure does not look correct for subsumption and classification.  GCIs may not be possible as they need defining attributes.

RE: #plasias.  Thomas Ruediger (Unlicensed)  supports a single set of morphologic abnormality concepts for glandular dysplasia, glandular intraepithelial neoplasia, squamous dysplasia, intraepithelial squamous neoplasia that are completely organ agnostic.

@ stefandubois suggests that such a conflation of concepts will require a comprehensive review by organ system.

In my opinion, both are correct.  This dovetails nicely into the Histology QI project.

The CSRWG needs to address what needs to/can be done to get the synoptic reporting content deliverable in the shorter term while also addressing the longer term Histology QI issue.

3

Missing body structures

Scott Campbell 

  1. Async?  Out of sync

Not discussed

4

Wilms tumor/nephroblastoma NICTIZ

Scott Campbell 

  1. requests from Elze de Groot

Scott Campbell to follow up.  Paul (Unlicensed) forwarded protocol

Scott Campbell meeting with Nictiz on Friday, 1/16/23

5

GU histologies

Scott Campbell 

  1. Looking for interested parties

@stefan dubois; @brian rous; @ross simpson will assist.  Scott Campbell will get meetings started.

6

Follow up on protocol review by authoritative bodies

Scott Campbell 

  1. Documents of SNOMED CT terminology binding across major protocol producers

Scott Campbell will forward marked up ICCR, RCPath protocols to team for review of SNOMED CT content bindings.

  1. ICCR

  2. CAP

Needs to be followed up in another meeting.

8

Business meeting

Scott Campbell 

  1. In person/mixed

2 > half days; Also pathology CRG will meet f2f

Meeting Files

 

 

 

Previous Meetings

Copyright © 2026, SNOMED International